Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
This review summarizes the drugs currently available for the treatment and prevention of BIPN, with the aim of providing insights for future drug development (Table 1)
Effects of disease states on intra-portal insulin levels and changes in the GH/IGF-I axis High GH and low IGF-I Type 1 diabetes is an autoimmune disease characterized by pancreatic -cell destruction leading to intra-portal hypoinsulinemia
Myths vs Reality Now, it is time to sort everything out and learn more facts related to this topic
10.1186/s13018-019-1242-6 [DOI] [PMC free article] [PubMed] [Google Scholar] Petek M., Sikiric P., Anic T., Buljat G., Separovic J., Stancic-Rokotov D., et al
US$ 21.19
US$ 20.23
US$ 28.83
US$ 29.96
US$ 24.41
US$ 27.23
